Aveo teams with Bris­tol My­ers af­ter sur­prise FDA ap­proval; Cal­ciMed­ica lines up $21M raise to ad­vance Covid-19 can­di­date

Aveo On­col­o­gy’s new­ly ap­proved drug doesn’t ex­tend lives, but hey, maybe it will when com­bined with Op­di­vo?

Aveo an­nounced Fri­day that it was launch­ing a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.